Monday, October 26, 2026 · Daily editionET --:--:--

Withdrawn before it began

Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)

NCT03762603 · Stanford University · Updated 11 April 2025

What is being tested
Robotic exoskeleton device
For
Primary Knee Replacement Surgery
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 99 years. The full rules are on the registry page.
Where
United States
When
Starts or started Sept 2025, ends 20 Dec 2027. Registered 4 Dec 2018.
Results
None posted yet.

In the researchers' words

This study involves an exoskeleton which is believed to increase quadriceps muscle strength in the rehabilitation phase after TKA and reduce the discharge the such patients in Extended care facility (ECF) . The purpose of this study is to access efficacy of the robotic exoskeleton device wrapped around the operated knee on patients
ClinicalTrials.gov, NCT03762603

Sites

  • Stanford University School of MedicinePalo Alto, California, United States